Newron Pharmaceuticals S.p.A. | Balance Sheet
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
22,580.70
30,903.20
44,507.80
49,813.50
70,305.60
49,418.70
Total Accounts Receivable
3,343.10
4,027.90
2,097.60
9,277.00
13,150.50
17,394
Inventories
368.90
122.60
41.30
5.40
5.90
-
Other Current Assets
419.10
281.40
1,170.00
1,085.90
1,727.20
252.40
Total Current Assets
26,711.80
35,335.10
47,816.70
60,181.80
85,189.10
67,065.10
Net Property, Plant & Equipment
96.80
80.60
85.90
128.60
125.20
119.50
Total Investments and Advances
715.70
702.20
-
-
-
-
Long-Term Note Receivable
40.40
50.50
67.40
75.00
96.00
93.50
Intangible Assets
11,182.50
8,408.10
288.20
279.80
41.00
33.80
Total Assets
38,747.20
44,576.50
48,258.20
60,665.30
85,451.20
67,311.90
ST Debt & Current Portion LT Debt
438.70
430.40
393.60
390.20
-
Accounts Payable
1,612.70
1,257.70
1,779.00
2,125.80
2,601.30
Other Current Liabilities
5,387.20
3,709.30
4,909.50
4,607.40
2,930.10
Total Current Liabilities
7,438.70
5,397.40
7,082.10
7,123.40
5,531.40
Long-Term Debt
1,332.10
876.50
395.80
-
-
Provision for Risks & Charges
571.10
393.20
343.60
132.90
674.00
Deferred Taxes
3,560.00
2,727.00
81.60
80.40
-
Total Liabilities
12,901.90
9,394.10
7,903.10
7,336.70
6,205.50
Common Equity (Total)
25,845.40
35,182.40
40,355.10
53,328.50
79,245.70
Total Shareholders' Equity
25,845.40
35,182.40
40,355.10
53,328.50
79,245.70
Total Equity
25,845.40
35,182.40
40,355.10
53,328.50
79,245.70
Liabilities & Shareholders' Equity
38,747.20
44,576.50
48,258.20
60,665.30
85,451.20
About Newron Pharmaceuticals
View Profile
